Skip to content

IRADIMED CORPORATION: 10-Q filed 2014-11-13

What IRADIMED CORPORATION reported in its quarterly report filed 2014-11-13 (fiscal Q3 2014): 45 published measures, 126 facts as tagged in accession 0001104659-14-080369.

This filing

Form
10-Q (quarterly report)
Filed
2014-11-13
Fiscal period
fiscal Q3 2014
Accession
0001104659-14-080369 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IRADIMED CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-09-3022,411,528USD
At 2013-12-316,986,871USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-09-302,260,590USD
At 2013-12-311,564,087USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-09-3020,150,938USD
At 2013-12-315,422,784USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-09-3018,113,859USD
At 2013-12-312,461,559USD
At 2013-09-302,042,989USD
At 2012-12-311,697,306USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-30237,357USD92
2014-01-01 to 2014-09-301,779,545USD273
2013-07-01 to 2013-09-30260,675USD92
2013-01-01 to 2013-09-301,462,910USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-09-30504,502USD273
2013-01-01 to 2013-09-30121,173USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-07-01 to 2014-09-303,811,947USD92
2014-01-01 to 2014-09-3012,069,553USD273
2013-07-01 to 2013-09-302,479,749USD92
2013-01-01 to 2013-09-307,883,071USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-274,130USD273
2013-01-01 to 2013-09-30-146,842USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-09-304,854,428USD
At 2013-12-313,074,883USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-07-01 to 2014-09-3010,112,139shares92
2014-01-01 to 2014-09-308,048,779shares273
2013-07-01 to 2013-09-307,000,000shares92
2013-01-01 to 2013-09-307,000,000shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-07-01 to 2014-09-3011,269,358shares92
2014-01-01 to 2014-09-309,688,602shares273
2013-07-01 to 2013-09-308,665,599shares92
2013-01-01 to 2013-09-308,562,704shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.02USD/shares92
2014-01-01 to 2014-09-300.22USD/shares273
2013-07-01 to 2013-09-300.04USD/shares92
2013-01-01 to 2013-09-300.21USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-07-01 to 2014-09-300.02USD/shares92
2014-01-01 to 2014-09-300.18USD/shares273
2013-07-01 to 2013-09-300.03USD/shares92
2013-01-01 to 2013-09-300.17USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-07-01 to 2014-09-30160,143USD92
2014-01-01 to 2014-09-301,067,242USD273
2013-07-01 to 2013-09-30113,983USD92
2013-01-01 to 2013-09-30639,678USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-09-30755,267USD
At 2013-12-31327,343USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-09-30503,881USD273
2013-01-01 to 2013-09-30203,939USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-07-01 to 2014-09-30406,308USD92
2014-01-01 to 2014-09-302,840,512USD273
2013-07-01 to 2013-09-30355,841USD92
2013-01-01 to 2013-09-302,064,372USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-09-3021,243,792USD
At 2013-12-316,386,607USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-09-302,100,203USD
At 2013-12-311,452,324USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-09-30640,235USD
At 2013-12-31427,474USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-09-30259,473USD
At 2013-12-31267,024USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-09-301,174,103USD
At 2013-12-311,982,083USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-07-01 to 2014-09-302,446,046USD92
2014-01-01 to 2014-09-306,743,337USD273
2013-07-01 to 2013-09-301,454,143USD92
2013-01-01 to 2013-09-303,914,102USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-09-301,639,977USD
At 2013-12-311,340,331USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-302,852,354USD92
2014-01-01 to 2014-09-309,583,849USD273
2013-07-01 to 2013-09-301,809,984USD92
2013-01-01 to 2013-09-305,978,474USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-07-01 to 2014-09-30959,593USD92
2014-01-01 to 2014-09-302,485,704USD273
2013-07-01 to 2013-09-30669,765USD92
2013-01-01 to 2013-09-301,904,597USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-07-01 to 2014-09-30303,463USD92
2014-01-01 to 2014-09-30753,267USD273
2013-07-01 to 2013-09-30299,422USD92
2013-01-01 to 2013-09-30664,257USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-09-3010,718,400shares
At 2013-12-317,000,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-09-3015,295,438USD
At 2013-12-312,346,137USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2013-12-31924USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-09-301,496,035USD
At 2013-12-311,057,775USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-09-30740,768USD
At 2013-12-31730,432USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-09-3021,866USD
At 2013-12-315,897USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-09-30247,937USD
At 2013-12-31119,974USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-07-01 to 2014-09-30397,500USD92
2014-01-01 to 2014-09-302,846,787USD273
2013-07-01 to 2013-09-30374,658USD92
2013-01-01 to 2013-09-302,102,588USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-07-01 to 2014-09-30237,357USD92
2014-01-01 to 2014-09-301,778,621USD273
2013-07-01 to 2013-09-30259,872USD92
2013-01-01 to 2013-09-301,457,931USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-07-01 to 2014-09-301,261,872USD92
2014-01-01 to 2014-09-303,485,051USD273
2013-07-01 to 2013-09-30640,987USD92
2013-01-01 to 2013-09-301,671,726USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-07-01 to 2014-09-3035,316USD92
2014-01-01 to 2014-09-3070,361USD273
2013-07-01 to 2013-09-3023,274USD92
2013-01-01 to 2013-09-3069,908USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-09-3099,638USD273
2013-01-01 to 2013-09-3097,945USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-07-01 to 2014-09-309,861USD92
2014-01-01 to 2014-09-3029,277USD273
2013-07-01 to 2013-09-309,480USD92
2013-01-01 to 2013-09-3028,037USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-07-01 to 2014-09-30-8,808USD92
2014-01-01 to 2014-09-306,275USD273
2013-07-01 to 2013-09-3018,817USD92
2013-01-01 to 2013-09-3038,216USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-09-3014,490,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30-807,980USD273
2013-01-01 to 2013-09-30129,914USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30336,355USD273
2013-01-01 to 2013-09-30279,055USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-09-30212,761USD273
2013-01-01 to 2013-09-3034,349USD273

Inspect the source

Entity
IRADIMED CORPORATION / CIK 0001325618
Captured
2026-09-20T07:52:33.517Z
SEC response SHA-256
1217db54631fdc625eb836a9c89fbf1ed157044af9ce59b6e200421c6d8ca994

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001325618.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))